Memantine as an Additive Therapy in Patients With Traumatic Brain Injury

NCT06914310 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Mild Traumatic Brain Injury
Moderate Traumatic Brain Injury (TBI)

Interventions

DRUG: Memantine
DRUG: Mannitol

Sponsor

Mansoura University